UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020307
Receipt No. R000023448
Official scientific title of the study A study for evaluating the effects of oral intake of lactic acid bacteria on immune function. A randomized, double-blind, placebo- controlled trial.
Date of disclosure of the study information 2015/12/24
Last modified on 2016/08/08 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A study for evaluating the effects of oral intake of lactic acid bacteria on immune function. A randomized, double-blind, placebo- controlled trial.
Title of the study (Brief title) A study for evaluating the effects of oral intake of lactic acid bacteria on immune function.
Region
Japan

Condition
Condition None (Healthy adults)
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of oral intake of lactic acid bacteria on immune functions.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation of cytokines production and expression levels of anti-viral genes of peripheral blood mononuclear cells stimulated by viruses at 4 weeks after intervention.
Key secondary outcomes Activities of dendritic cells in peripheral blood at 4 weeks after intervention. (Cell surface expression levels of dendritic cells makers.)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Lactic acid bacteria, 1 portion of food per day for 4 weeks.
Interventions/Control_2 Placebo (not containing lactic acid bacteria), 1 portion of food per day for 4 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1)Males and females aged from 20 to less than 65 years old, when giving the informed consent.
2)Individuals who have low activities of immune cells in peripheral blood.
3)Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will.
Key exclusion criteria 1)Individuals who can't stop drinking for 2 days until the screening and each checkup.
2)Individuals who can't stop eating foods containing lactic acid bacteria and oligosaccharide during this study.
3)Individuals who can't stop eating foods which may activate immune functions.
4)Individuals who have tendency to get diarrhea by eating dairy product.
5)Individuals who have a history of irritable bowel syndrome and Crohn's disease.
6)Individuals who was vaccinated and who may receive it this year.
7)Individuals who have a medical history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder.
8)Individuals who have chronic diseases and use medicines continuously.
9)Individuals who have under treatment or a history of drug addiction and/or alcoholism.
10)Individuals who are judged as unsuitable for the study based on the results of blood test.
11)Individuals with excessive alcohol-drinking behaviors.
12)Individuals who have a medical history of diseases affecting digestion and absorption.
13)Individuals who have a medical history of hay fever.
14)Individuals having food allergy.
15)Individuals who are pregnant, breastfeeding, or planning to be pregnant in the near future.
16)Individuals who are participating or willing to participate in other clinical trials or in the last 3 months.
17)Individuals who and whose family work for a company manufacturing or selling healthy foods or functional foods.
18)Individuals who are judged unsuitable for this study by the investigator for other reasons.
Target sample size 100

Research contact person
Name of lead principal investigator Haruhi Sugimura
Organization C'est la vie Shimbashi Clinic
Division name Medical office
Address 2-39-3 Nishishimbashi, Minato-ku, Tokyo
TEL 03-5408-8671
Email h-sugimura@shinkokai.jp

Public contact
Name of contact person Eiji Yoshikawa
Organization KSO Corporation
Division name Sales department
Address 1-9-7 Shibaura, Minato-ku, Tokyo, Japan
TEL 03-3452-7733
Homepage URL
Email yoshikawa@kso.co.jp

Sponsor
Institute KSO Corporation
Institute
Department

Funding Source
Organization Kirin Company, Limited
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団進興会 セラヴィ新橋クリニック/Medical Corporation Shinkou Kai C'est la vie Shinbashi Clinic

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 24 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 11 Day
Anticipated trial start date
2015 Year 12 Month 25 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 22 Day
Last modified on
2016 Year 08 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023448